CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring

This study has been terminated.
(Sponsor's decision.)
Sponsor:
Information provided by (Responsible Party):
Biogen
ClinicalTrials.gov Identifier:
NCT00707512
First received: June 27, 2008
Last updated: July 16, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: August 2050
  Estimated Primary Completion Date: August 2050 (Final data collection date for primary outcome measure)